Press release
Nonmelanoma Skin Cancer Market Poised for Significant Growth by 2034 as Novel Therapies Emerge | DelveInsight
The Nonmelanoma Skin Cancer market is expected to experience substantial growth from 2024 to 2034, driven by increasing disease prevalence, advancements in diagnostic techniques, and the introduction of novel treatment options. As research progresses, new therapies will likely address existing treatment gaps, enhancing patient care and market growth. Leading Nonmelanoma Skin Cancer companies actively advancing research in this landscape include Sensus Healthcare, DUSA Pharmaceuticals Inc., Skin Analytics Limited, Pfizer, Bristol-Myers Squibb, Sirnaomics, AiViva BioPharma, and Exicure, among others.
DelveInsight's "Nonmelanoma Skin Cancer Market Insight, Epidemiology, and Market Forecast - 2034" report delivers comprehensive insights into the rapidly evolving Nonmelanoma Skin Cancer treatment market across 7MM. The Nonmelanoma Skin Cancer market is projected to experience substantial growth during the 2024-2034 forecast period, driven by increasing disease prevalence, enhanced diagnostic capabilities, and the introduction of innovative treatment options. This growth trajectory reflects the expanding Nonmelanoma Skin Cancer patient pool and the robust development pipeline aimed at addressing significant unmet needs in this therapeutic area.
Download the Nonmelanoma Skin Cancer market report to understand which factors are driving the Nonmelanoma Skin Cancer therapeutic market @ Nonmelanoma Skin Cancer Market Trends [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
The Nonmelanoma Skin Cancer epidemiology landscape reveals that around 3.6 million cases of BCC and 2 million cases of SCC are diagnosed annually in the US. Moreover, the incidence of BCC was nearly equal between men and women, whereas SCC showed a slightly higher prevalence in women compared to men, suggesting a potential gender difference in the distribution of these skin cancers.
The report provides historical as well as forecasted Nonmelanoma Skin Cancer epidemiology segmented as Total Nonmelanoma Skin Cancer prevalent cases, Total diagnosed prevalent cases of Nonmelanoma Skin Cancer, Gender-specific diagnosed prevalent cases of Nonmelanoma Skin Cancer, Age-specific diagnosed prevalent cases of Nonmelanoma Skin Cancer, Region-specific diagnosed prevalent cases of Nonmelanoma Skin Cancer, and Treatable cases of Nonmelanoma Skin Cancer in the 7MM.
The report also discusses the current and emerging treatment of nonmelanoma skin cancer. The treatment market continues to evolve beyond conventional surgical approaches, which remain primary interventions. Current treatment options include topical therapies like imiquimod and 5-fluorouracil, photodynamic therapy, radiotherapy, and electrochemotherapy for certain cases. For advanced or metastatic disease, systemic chemotherapy utilizing drugs such as cisplatin and paclitaxel may be employed, with immunotherapy agents increasingly demonstrating efficacy in this patient population.
The current Nonmelanoma Skin Cancer treatment market features several established therapies that have reshaped patient care. VISMODEGIB (Erivedge), developed by Genentech, stands as the first FDA-approved pharmacologic agent targeting the Hedgehog signaling pathway for basal cell carcinoma patients who aren't candidates for surgery or radiation. Complementing this approach, Sanofi's LIBTAYO (cemiplimab-rwlc) gained FDA approval in September 2021 as the first immunotherapy for advanced basal cell carcinoma previously treated with a hedgehog pathway inhibitor.
The Nonmelanoma Skin Cancer therapeutics market also includes ODOMZO (Sun Pharma) and KEYTRUDA (Merck & Co), among others. KEYTRUDA (Merck & Co) received FDA approval for patients with recurrent or metastatic cutaneous squamous cell carcinoma not amenable to surgery or radiation.
Discover evolving trends in the Nonmelanoma Skin Cancer treatment landscape @ Nonmelanoma Skin Cancer Therapeutics [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]Market [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Additionally, AiViva BioPharma's AIV001 recently received FDA clearance in December 2024 for intradermal injection testing facial skin for nonmelanoma skin cancer, specifically basal cell carcinoma. Another investigational drug, RP1 (Replimune Group), received the FDA Breakthrough Therapy designation in November 2024.
Among the most promising emerging therapies, Sirnaomics' STP705 represents an innovative siRNA therapeutic leveraging proprietary dual-targeted inhibitory properties. Currently in Phase II trials for both basal cell carcinoma and cutaneous squamous cell carcinoma, this therapy exemplifies the scientific advancement characterizing the Nonmelanoma Skin Cancer drug market.
The Nonmelanoma Skin Cancer pipeline features several novel therapeutic approaches poised to impact the treatment paradigm significantly. Leading Nonmelanoma Skin Cancer companies actively advancing research include Sensus Healthcare, DUSA Pharmaceuticals Inc., Skin Analytics Limited, Pfizer, Bristol-Myers Squibb, Sirnaomics, AiViva BioPharma, and Exicure, among others. These industry leaders are driving innovation across the Nonmelanoma Skin Cancer treatment landscape, with several promising candidates progressing through clinical development.
Recently, according to the results published in April 2025, Silmitasertib (Senhwa Biosciences), which is being explored for patients who have relapsed after standard therapies, including hedgehog pathway and PD-1 inhibitors, showed progression-free survival exceeding 21 months in several patients in a Phase 1 dose-expansion trial for advanced BCC. Another study published in January 2025 demonstrated a 97% calculated objective response rate for VP-315 (Verrica Pharmaceuticals) in Part 2 of a Phase 2 study.
Unlock which Nonmelanoma Skin Cancer drug is expected to capture the largest market share in 7MM by 2032. Visit the Nonmelanoma Skin Cancer Market Insights [https://www.delveinsight.com/sample-request/nonmelanoma-skin-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Despite the positive growth outlook, the Nonmelanoma Skin Cancer market faces challenges, including side effects for treatments such as radiation therapy and chemotherapy, pricing concerns, a lack of awareness about the disease among patients and healthcare providers, late diagnosis, reimbursement issues, and healthcare specialist shortages. Nevertheless, the forecasted period will likely witness transformative advances as emerging therapies address existing treatment gaps and expand therapeutic options for the substantial Nonmelanoma Skin Cancer patient population.
Table of Contents
1.
Key insights
2.
Executive Summary of Nonmelanoma Skin Cancer
3.
Nonmelanoma Skin Cancer: Market Overview at a Glance
4.
Disease Background and Overview: Nonmelanoma Skin Cancer
5.
Nonmelanoma Skin Cancer Treatment & Medical Practices
6.
Nonmelanoma Skin Cancer Patient Journey
7.
Nonmelanoma Skin Cancer Epidemiology and Patient Population
8.
NMSC: Country-Wise Epidemiology
9.
Nonmelanoma Skin Cancer Marketed Products
10.
Nonmelanoma Skin Cancer Emerging Therapies
11.
Nonmelanoma Skin Cancer Pipeline Profiles
12.
Nonmelanoma Skin Cancer: Market Size of NMSC
13.
7MM NMSC: Country-Wise Market Analysis
14.
SWOT Analysis
15.
KOL Views
16.
Nonmelanoma Skin Cancer Reimbursement and Market Access
17.
Appendix
18.
DelveInsight Capabilities
19.
Disclaimer
20.
About DelveInsight
Related Reports
Nonmelanoma Skin Cancer Pipeline Insight [https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Nonmelanoma Skin Cancer Pipeline Insight provides comprehensive insights about the Nonmelanoma Skin Cancer pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the Nonmelanoma Skin Cancer companies, including Sensus Healthcare, DUSA Pharmaceuticals Inc., Skin Analytics Limited, Pfizer, Bristol-Myers Squibb, Sirnaomics, AiViva BioPharma, and Exicure, among others.
About DelveInsight
DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nonmelanoma-skin-cancer-market-poised-for-significant-growth-by-2034-as-novel-therapies-emerge-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nonmelanoma Skin Cancer Market Poised for Significant Growth by 2034 as Novel Therapies Emerge | DelveInsight here
News-ID: 3963993 • Views: …
More Releases from ABNewswire
Rialto-Based Get it from Bo Pioneers Collaborative E-Commerce Model Supporting M …
Get it from Bo revolutionizes online retail through strategic manufacturer partnerships that deliver quality products at reasonable prices. The California-based platform, established in 2024, creates sustainable business relationships while expanding inventory daily to serve diverse consumer needs.
Get it from Bo is establishing new standards in the e-commerce industry through its innovative collaborative approach that prioritizes sustainable partnerships with manufacturers and brands while delivering exceptional value to consumers. The Rialto, California-based…
Daily Vibe Launches Comprehensive Fitness Products Store for Diverse Consumer Ma …
New fitness retailer Daily Vibe enters the market with targeted product selections designed to support active lifestyles across multiple demographics. The startup focuses on serving fitness enthusiasts, health-conscious consumers, and older adults seeking quality fitness products.
Founded by Ja'von L. Watson and Joyleena S. Watson, AGAIT International is a fast-growing Atlanta-based tech company dedicated to solving social and economic challenges through creative business and digital solutions. The company develops and manages…
Prolift Handling Brings Advanced pewag Lifting Technology to Ireland
Prolift Handling launches pewag levo Balancer and levo Compensator in Ireland - two advanced lifting solutions that improve safety and precision in heavy lifting operations through remote-controlled positioning and automatic load balancing.
Dublin, Ireland - Sep 30, 2025 - Prolift Handling, Ireland's exclusive pewag partner, today launched two advanced lifting solutions designed to tackle the industry's most challenging safety and precision requirements: the pewag levo Balancer and pewag levo Compensator.
The pewag…
A Gem of Joy ABA Breaks Barriers to Access with In-Home Therapy Services for Fam …
A Gem of Joy ABA offers in-home therapy services for Maryland families, breaking barriers to access and providing personalized support for children's development.
Maryland - A Gem of Joy ABA, a leading provider of autism therapy solutions, is making a transformative impact on families across Maryland by offering flexible and personalized in-home ABA Therapy. This innovative approach aims to break down barriers to care by delivering services directly to families' homes,…
More Releases for Skin
Rising Skin Disease Prevalence Fueling Growth In Complicated Skin And Skin Struc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Complicated Skin And Skin Structure Infections Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of drugs for complex skin and skin structure infections has seen robust growth. The market value will rise from $9.51 billion in 2024 to…
Pipa Skin Care Introduces Skin Saver: The Ultimate Face and Body Mist for Tweens …
[MIAMI, FL - March 2025] Pipa Skin Care, the science-backed and pediatrician-approved skincare brand designed specifically for tweens with clean and safe ingredients, is launching Skin Saver (MSRP $16.99), a revolutionary face and body mist that helps fight acne-causing bacteria, calm irritation, and restore skin balance-all with just three clean ingredients.
At the core of Skin Saver is hypochlorous acid (HOCl), a powerful, dermatologist-recommended ingredient naturally found in the human immune…
Natural Skin Essence Skin Tag Remover - Affordable Skin Tag Remover!
Skin tags are small, benign growths that appear on the skin. While they are generally harmless, many people find them unsightly and choose to remove them. Natural Skin Essence Skin Tag Remover has emerged as a popular, non-invasive solution for removing skin tags without the need for expensive and painful procedures. This article will delve into everything you need to know about Natural Skin Essence Skin Tag Remover, including its…
Skin Solutions Skin Tag Remover - Remove Unwanted Skin Tags Painlessly!
Are you tired of unsightly skin tags? You're not alone. Skin tags, though harmless, can be an aesthetic concern for many. They often appear in inconvenient places and can affect your confidence. Fortunately, there's a solution: Skin Solutions Skin Tag Remover. In this article, we'll explore everything you need to know about this popular skin tag removal product.
● Product Name - Skin Solutions Skin Tag Remover
● Main Benefits - Skin…
Allura Skin Glow Skin Tag Remover Eliminate Bothersome Skin Growths!
Are you frustrated with having to conceal your scars and wrinkles under layers of clothing? Do these skin issues make you feel embarrassed and self-conscious? Worry no more, because Allura Skin Glow Skin Tag Remover is the solution you've been looking for! This powerful serum targets blemishes and marks on your skin, helping you achieve flawless, silky-smooth skin quickly. In this article, we'll provide you with all the essential information…
Skin Arcadia Skin Tag Remover Voted #1 Skin Tag Remover!
Skin tags can be an unpleasant and annoying skin problem. These little, soft developments of skin normally appear on the neck, underarms, under the breasts, or in skin folds. While safe, many individuals turn to removal methods to eliminate these bothersome skin tags. Skin Arcadia Skin Tag Remover provides an all-natural, at-home option for removing skin tags without pain or scarring.
𝐒𝐇𝐈𝐏𝐏𝐈𝐍𝐆 𝐅𝐄𝐄 𝐎𝐍𝐋𝐘!!
📣𝗦𝗮𝗹𝗲 𝗶𝘀 𝗟𝗶𝘃𝗲 𝗡𝗼𝘄 👉👉 https://atozsupplement.com/skin-arcadia-skin-tag-remover/
✅Enjoy Your Bottle!!
What…
